HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Symposium on Advanced Wound Care: Regenative Labs to Present Its Groundbreaking Wharton’s Jelly Studies

Regenative Labs (will present two scientific studies demonstrating the efficacy of Wharton's jelly allografts in complicated post-surgical wounds and late-stage sacral decubitus ulcers.

Newly-Published Data Demonstrates Safety and Efficacy of World’s First Minimally Invasive Brain Pacemaker

New data just published online in the prestigious journal JAMA Neurology has demonstrated the safety and efficacy of EASEE®, the world's first minimally invasive brain pacemaker, in patients with focal epilepsy resistant to drug therapy.

A New Study Suggests Energy4Life’s Bioenergetic Wearable Device May Have Positive Effects on Cellular Membrane

“Our bioenergetic wearables are designed to communicate directly to the body, thus triggering its self-repair system,” said Harry Massey, founder and CEO of Energy4Life. “Digitized biological information allows you to help turn on the body's self-repair system – impacting the physics of the body - which in turn directs all other activity of the body,” stated Massey.

Inspira Technologies Announces First in Human of HYLA Blood Sensor in Clinical Study

The HYLA Blood sensor is a non-invasive optical blood sensor, being developed using machine learning based algorithms to measure blood key parameters, continuously and in real-time during extracorporeal procedures including VV-ECMO, VA-ECMO and open-heart surgery.

Ancora Heart’s AccuCinch System Demonstrates Significant Improvement in Quality of Life, Cardiac Structure and Function in Heart Failure Patients

Dr. Hamid. “We witnessed significant and progressive reverse remodeling of the left ventricle, as well as significant and sustained improvement in quality of life and functional capacity measures. These results show promise that this innovative catheter-based therapy may help broaden options for treating patients with heart failure, and we look forward to results of the pivotal study that’s underway.”

Todd Lanman MD Announces Completion of First Lumbar Total Joint Replacement Procedure in California as Part of a Clinical Trial

Tom Lanman MD “The century-old ‘go-to’ procedure of fusing the spine should be a thing of the past. We strongly believe that at least half of fusions in the U.S. should never have been done in the first place. Every other joint in the body gets a replacement, and the spine should be no different.”

DermaSensor Unveils Study Results Demonstrating the Ability to Detect Skin Cancer with Device Granted FDA Breakthrough Designation

“It is an honor to have been selected to present data at the AAD from our two major clinical validation studies, which are two of our four studies serving as principal support for our FDA submission,” said DermaSensor’s CEO, Cody Simmons. “Having spent a decade miniaturizing and conducting studies with our spectroscopy technology, we hope to soon equip PCPs in the U.S. with our handheld, wireless device in order to improve their detection and referral of skin cancer, which is more common than all other cancers combined.”

Over 1,000 Patients Enrolled in Landmark SELUTION DeNovo Study

SELUTION DeNovo compares the treatment strategy using a novel sirolimus drug-eluting balloon [DEB SELUTION], versus a limus drug-eluting stent [DES].

AI Accurately Identifies Normal and Abnormal Chest X-rays

An AI tool that can accurately differentiate between normal and abnormal chest X-rays would greatly alleviate the heavy workload experienced by radiologists globally.
Exit mobile version